03 Aug CASE STUDY: GOOD THERAPEUTICS
This is a case study of RiverVest portfolio company Good Therapeutics, which was acquired by Roche in 2022 for $250 million upfront plus potential milestone returns....
24 Apr CASE STUDY: Standard Bariatrics
This is a case study of RiverVest's role in financing and guiding Cincinnati-based portfolio company Standard Bariatrics through acquisition by Teleflex, Inc....
13 Feb CASE STUDY: Lumena Pharmaceuticals
RiverVest co-founded and seed funded Lumena and built a clinical strategy to fast-track its lead drug compound through clinical trials....
22 Jan CASE STUDY: Mirum Pharmaceuticals (Lumena 2.0)
After the drug compound they developed was deprioritized, the Lumena team bought it back so they could finish what they started – getting kids with rare liver disease the relief they need. ...